VeriMomIst butylene glycol dicaprylate/dicaprate in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
Pregnancy-safe products containing butylene glycol dicaprylate/dicaprate
Related ingredients
Frequently asked questions
- Ist butylene glycol dicaprylate/dicaprate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
- Ist butylene glycol dicaprylate/dicaprate während des Stillens sicher?
- No evidence of lactation/transfer concerns or reproductive toxicity in available regulatory/peer review sources. Given low dermal absorption from topical esters, maternal systemic exposure from cosmetic use is expected to be low; no data for milk transfer were found.
- Ist butylene glycol dicaprylate/dicaprate sicher für Babyhaut?
- No infant‑specific reproductive or developmental hazards identified. Because infant skin has higher surface‑area‑to‑weight and an immature barrier, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Ingredient is used as an emollient/skin conditioning agent (CosIng/PubChem) with no infant‑specific restrictions identified.
- Wie bewertet VeriMom butylene glycol dicaprylate/dicaprate?
- VeriMom bewertet butylene glycol dicaprylate/dicaprate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu butylene glycol dicaprylate/dicaprate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu butylene glycol dicaprylate/dicaprate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.